Concepedia

Kristin Bullok

KB

Statistics

Publications

4

Citations

271

H-Index

4

Active since

2005

Affiliations

Eli Lilly (United States)(Current)

Kristin Bullok is an author at Eli Lilly (United States) specializing in apoptosis, molecular probe development, and general internal medicine.

Publications per year

2005–2021

4

Publications

4

Synthesis and Characterization of a Small, Membrane-Permeant, Caspase-Activatable Far-Red Fluorescent Peptide for Imaging Apoptosis

Kristin Bullok, David Piwnica‐Worms · Journal of Medicinal Chemistry · 2005 · 136 citations

Life Sciences, Cell Biology, Molecular Biology +16

TAT-BH4 and TAT-Bcl-xL Peptides Protect against Sepsis-Induced Lymphocyte Apoptosis In Vivo

Richard S. Hotchkiss, Kevin W. McConnell, Kristin Bullok et al. · The Journal of Immunology · 2006 · 111 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Patient Preferences in Rare Diseases: A Qualitative Study in Neuromuscular Disorders to Inform a Quantitative Preference Study

Cecilia Jimenez‐Moreno, Eline van Overbeeke, Cathy Anne Pinto et al. · Patient · 2021 · 13 citations · Full text

Medicine, Neurology, Clinical Medicine +13

Incorporation of a Benefit-Risk Assessment Framework Into the Clinical Overview of Marketing Authorization Applications

Anne M. Wolka, Margaret R. Warner, Kristin Bullok et al. · Therapeutic Innovation & Regulatory Science · 2015 · 11 citations

Pharmacy, Risk Management, Risk Analysis +14

1–4 of 4